The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia.
14. Juni 2023M. Groschel, C. Meehan, I. Barilar, M. Diricks, A. Gonzaga, M. Steglich, O. Conchillo-Sole, I. Scherer, U. Mamat, C. Luz,…Eravacycline for antimicrobial susceptibility testing of Enterobacteriaceae and Enterococcus spp.: performance results from a multi-centre study.
14. Juni 2023L. Blanchard, T. Armstrong, D. Gerald, Y. Ying, M. Kresken, J. Carpenter, V. Sauvonnet, G. Zambardi. Eravacycline for antimicrobial susceptibility testing…In vitro activity of ceftazidime/avibactam against ceftazidime-resistant Enterobacterales and Pseudomonas aeruginosa from hospitalised patients in Germany
14. Juni 2023M. Kresken, M. Korte-Berwanger, N. Pfennigwerth, S. Gatermann. In vitro activity of ceftazidime/avibactam against ceftazidime-resistant Enterobacterales and Pseudomonas aeruginosa from hospitalised patients in…Genome-based surveillance of clinical vancomycin-resistant Enterococcus faecium reveals increased prevalence of vanB-type isolates of ST117/CT71 in German hospitals
14. Juni 2023B. Neumann, M. Kresken, G. Werner. Genome-based surveillance of clinical vancomycin-resistant Enterococcus faecium reveals increased prevalence of vanB-type isolates of ST117/CT71 in German…Die veränderte Definition von SIR bei Empfindlichkeitstestungen nach EUCAST.Krankenhaushygiene up2date 2020; 15: 395–403
31. Mai 2023Gatermann S, Hamprecht A, Kresken M.The VRE study group. Thirty years of VRE in Germany – “expect the unexpected”: The view from the National Reference Centre for Staphylococci and Enterococci. Drug Resist Updat 53 (2020) 100732
31. Mai 2023Werner G, Neumann B, Weber RE, Kresken M, Wendt C, Bender JK.Temocillin susceptibility in Enterobacterales with an ESBL/AmpC-phenotype. Int J Antimicrob Agents. 2020; In Press, Journal Pre-proof, Available online 7 November 2020.
31. Mai 2023Kresken M, Pfeifer Y, Werner G.In vitro activity of cefiderocol against aerobic Gram-negative bacterial pathogens from Germany. Int J Antimicrob Agents. 2020; 56:106128.
31. Mai 2023Kresken M, Korte-Berwanger M, Gatermann SG, Pfeifer Y, Pfennigwerth N, Seifert H, Werner G.The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia. Nat Commun. 2020 Apr 27;11(1):2044. doi: 10.1038/s41467-020-15123-0.
31. Mai 2023Gröschel MI, Meehan CJ, Barilar I, Diricks M, Gonzaga A, Steglich M, Conchillo-Solé O, Scherer IC, Mamat U, Luz CF,…Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany. Int J Antimicrob Agents. 2020; 55(6): 105959 doi: 10.1016/j.ijantimicag.2020.105959.
31. Mai 2023Kresken M, Körber-Irrgang B, Korte-Berwanger M, Pfennigwerth N, Gatermann SG, Seifert H; German Carbapenem Resistance Study Group.